Literature DB >> 20694765

Sleep apnea is common in patients with coronary artery disease.

Christian Prinz1, Thomas Bitter, Cornelia Piper, Dieter Horstkotte, Lothar Faber, Olaf Oldenburg.   

Abstract

Sleep-disordered breathing (SDB) has a prognostic impact in patients with cardiac diseases. We included 257 patients with preserved left ventricular function and angiographically proven coronary artery disease (CAD). All patients underwent cardiorespiratory polygraphy. In 251 patients high-sensitive C-reactive protein and fibrinogen were measured. SDB was documented in 188 patients (apnea-hypopnea-index [AHI] 16.4+/- 1.9/h): 58 patients presented central sleep apnea (CSA) and 130 patients obstructive sleep apnea (OSA). All patients (73%) with SDB had higher blood fibrinogen levels than those without SDB (p = 0.01). We found 197 patients with CRP-values below the cut-off of 0.5 mg/dl (group 1) and 54 patients with no active infection but CRP>0.5 mg/dl (group 2). Severity of SDB was significantly higher in group 2 (p = 0.01). SDB has a high prevalence in CAD patients and seems to be associated with chronic inflammation, which may be linked to CAD progression and/or acute coronary events.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694765     DOI: 10.1007/s10354-009-0737-x

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  32 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?

Authors:  J Hedner; H Ejnell; J Sellgren; T Hedner; G Wallin
Journal:  J Hypertens Suppl       Date:  1988-12

3.  Respiratory disturbance index: an independent predictor of mortality in coronary artery disease.

Authors:  Y Peker; J Hedner; H Kraiczi; S Löth
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

4.  [Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure].

Authors:  O Oldenburg; B Lamp; V Töpfer; L Faber; H Teschler; D Horstkotte
Journal:  Dtsch Med Wochenschr       Date:  2007-03-30       Impact factor: 0.628

5.  Sleep-disordered breathing and coronary artery disease: long-term prognosis.

Authors:  T Mooe; K A Franklin; K Holmström; T Rabben; U Wiklund
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

6.  Changes in extracranial arteries in obstructive sleep apnoea.

Authors:  R Schulz; W Seeger; C Fegbeutel; H Hüsken; R H Bödeker; H Tillmanns; M Grebe
Journal:  Eur Respir J       Date:  2005-01       Impact factor: 16.671

7.  Hypercoagulability in patients with obstructive sleep apnea.

Authors:  J J Guardiola; P J Matheson; L C Clavijo; M A Wilson; E C Fletcher
Journal:  Sleep Med       Date:  2001-11       Impact factor: 3.492

8.  Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk.

Authors:  Paola A Lanfranchi; Virend K Somers; Alberto Braghiroli; Ugo Corra; Ermanno Eleuteri; Pantaleo Giannuzzi
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

9.  Endothelial function in obstructive sleep apnea and response to treatment.

Authors:  Mary S M Ip; Hung-Fat Tse; Bing Lam; Kenneth W T Tsang; Wah-Kit Lam
Journal:  Am J Respir Crit Care Med       Date:  2003-10-09       Impact factor: 21.405

10.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

View more
  12 in total

Review 1.  Phosphinic peptides as zinc metalloproteinase inhibitors.

Authors:  V Dive; D Georgiadis; M Matziari; A Makaritis; F Beau; P Cuniasse; A Yiotakis
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 2.  Obstructive sleep apnea: an emerging risk factor for atherosclerosis.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  Chest       Date:  2011-08       Impact factor: 9.410

3.  Screening for obstructive sleep apnea in veterans with ischemic heart disease using a computer-based clinical decision-support system.

Authors:  Rachel Laporta; Anil Anandam; Ali A El-Solh
Journal:  Clin Res Cardiol       Date:  2012-04-03       Impact factor: 5.460

Review 4.  Sleep Disordered Breathing and the Pathogenesis of Atrial Fibrillation.

Authors:  Thomas Bitter; Dieter Horstkotte; Olaf Oldenburg
Journal:  J Atr Fibrillation       Date:  2013-06-30

5.  Central Sleep Apnea in Patients due to Severe Aortic Stenosis.

Authors:  Christian Prinz; Thomas Bitter; Olaf Oldenburg; Lothar Faber; Dieter Horstkotte; Cornelia Piper
Journal:  Case Rep Med       Date:  2010-06-14

Review 6.  [Sleep-related breathing disorders and (resulting) cardiovascular diseases].

Authors:  O Oldenburg; T Bitter; H Fox; D Horstkotte
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

Review 7.  Sleeping Beauty or the Beast? - Metabolic Syndrome from an Obstructive Sleep Apnoea Perspective.

Authors:  Lise Tarnow; Brigitte Klinkenbijl; Holger Woehrle
Journal:  Eur Endocrinol       Date:  2013-03-15

8.  Sleep-disordered breathing and inappropriate defibrillator shocks in chronic heart failure.

Authors:  Thomas Bitter; Klaus-Jürgen Gutleben; Georg Nölker; Zisis Dimitriadis; Christian Prinz; Jürgen Vogt; Dieter Horstkotte; Olaf Oldenburg
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-07-29

9.  Development and Validation of Sleep Disturbance Questionnaire in Patients with Acute Coronary Syndrome.

Authors:  Elham Sepahvand; Rostam Jalali; Behnam Khaledi Paveh; Mansour Rezaei
Journal:  Int Sch Res Notices       Date:  2014-10-22

10.  Lack of reliable clinical predictors to identify obstructive sleep apnea in patients with hypertrophic cardiomyopathy.

Authors:  Flávia B Nerbass; Rodrigo P Pedrosa; Pedro R Genta; Murillo O Antunes; Edmundo Arteaga-Fernández; Luciano F Drager; Geraldo Lorenzi-Filho
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.